Bentham Science Logo

Track Your Manuscript:


Current Gene Therapy

Volume 21, 5 Issues, 2021
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access

Manuscript Transfer Facility

If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.

Transfer of Submission

Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.

Step 1.

The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.

Step 2.

The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.

Step 3.

The Author then receives an editorial decision from the journal.

Selection of another Journal

The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.

Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.

Editor-in-Chief

Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Gene Therapy Journal was launched in 2001. Dr. Ignacio Anegon was the founding editor of the journal.
New eBook

Probing Intracellular Regulation



You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog